Palantir stock slips 8% as the bleeding gets worse
Palantir (PLTR) (PLRTR) extended its decline on Monday morning following last week’s plunge that was driven by a new share sales initiative by the CEO and a media report of potential U.S. defense budget cuts. The stock is now about 30% down from its 2025 peak earlier this month.Read more...


Palantir (PLTR) (PLRTR) extended its decline on Monday morning following last week’s plunge that was driven by a new share sales initiative by the CEO and a media report of potential U.S. defense budget cuts. The stock is now about 30% down from its 2025 peak earlier this month.